CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues:
Uranium sales	$ 0		$ 0
Total revenue	0		0
Cost of uranium sales
Operating expenses	133,753	67,260	498,862	297,570
Accretion/amortization of asset retirement obligations	26,543	39,143	95,562	116,431
Depreciation and depletion	145,193	186,603	476,375	576,449
Impairment of uranium properties	493,568	352,631	1,081,666	742,278
Exploration expenses	(25,816)		82,871	725
Total cost of uranium sales	773,241	645,637	2,235,336	1,733,453
Loss from operations before corporate expenses	(773,241)	(645,637)	(2,235,336)	(1,733,453)
Corporate expenses-
General and administrative	2,022,139	1,674,030	6,289,557	4,852,642
Provision for legal settlement		1,375,000		1,375,000
Depreciation	31,717	36,331	100,383	107,581
Total corporate expenses	2,053,856	3,085,361	6,389,940	6,335,223
Loss from operations	(2,827,097)	(3,730,998)	(8,625,276)	(8,068,676)
Other income (expense):
Interest expense	(4,395)	(7,597)	(15,000)	(18,430)
Interest and other income, net	44,246	74,114	133,856	353,919
Net loss	$ (2,787,246)	$ (3,664,481)	$ (8,506,420)	$ (7,733,187)
Net loss per common share:
Basic (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.09)	$ (0.12)
Diluted (in dollars per share)	$ (0.03)	$ (0.04)	$ (0.09)	$ (0.12)
Weighted average common shares and common equivalent shares per share data:
Basic (in shares)	93,528,362	83,720,754	93,407,739	66,558,635
Diluted (in shares)	93,528,362	83,720,754	93,407,739	66,558,635